Press Release March 9, 2022C4 Therapeutics Announces FDA Orphan Drug Designation for CFT8634 for the Treatment of Soft Tissue Sarcoma 0 0 Share
Company Ticker News March 8, 2022C4 Therapeutics to Present at the American Association for Cancer Research (AACR) Annual Meeting 2022 0 0 Share
Company Ticker News February 24, 2022C4 Therapeutics Reports Full Year 2021 Financial Results and Recent Business Highlights 0 0 Share
Press Release January 10, 2022C4 Therapeutics Announces 2022 Key Milestones to Advance Targeted Protein Degradation Portfolio 0 0 Share
Company Ticker News January 3, 2022C4 Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference 0 0 Share
Company Ticker News December 29, 2021What Makes C4 Therapeutics, Inc. (CCCC) a New Buy Stock 0 0 Share
Press Release December 1, 2021C4 Therapeutics (CCCC) Sees Hammer Chart Pattern: Time to Buy? 0 0 Share
Press Release November 22, 2021C4 Therapeutics, Inc. (CCCC) Moves to Buy: Rationale Behind the Upgrade 0 0 Share
